A tetrazolato-bridged dinuclear platinum(II) Complex exhibits markedly high invivo antitumor activity against pancreatic cancer

ChemMedChem

Volumn 6, Issue 6, 2011, Pages 987-990

  Komeda, Seiji ^a   Lin, Yuh Ling ^b   Chikuma, Masahiko ^c  

^a SUZUKA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Antitumor agents; Cancer; Dinuclear; Platinum; Tetrazoles

Indexed keywords

CISPLATIN; GEMCITABINE; PLATINUM COMPLEX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CHEMICAL BOND; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DRUG DESIGN; DRUG EFFICACY; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IC 50; IN VIVO STUDY; MOUSE; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; STRUCTURE ANALYSIS; TUMOR VOLUME; WEIGHT REDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; BODY WEIGHT; CELL LINE, TUMOR; CELL SURVIVAL; HUMANS; MICE; MICE, NUDE; PANCREATIC NEOPLASMS; PLATINUM COMPOUNDS; TETRAZOLES;

EID: 79957625744     PISSN: 18607179     EISSN: 18607187     Source Type: Journal    
DOI: 10.1002/cmdc.201100141     Document Type: Article

References (19)

1. B. Rosenberg, L. VanCamp, J. E. Trosko, V. H. Mansour, Nature 1969, 222, 385.
2. G. Pratesi, P. Perego, D. Polizzi, S. C. Righetti, R. Supino, C. Caserini, C. Manzotti, F. C. Giuliani, G. Pezzoni, S. Tognella, S. Spinelli, N. Farrell, F. Zunino, Br. J. Cancer 1999, 80, 1912.
3. Z. Ma, J. R. Choudhury, M. W. Wright, C. S. Day, G. Saluta, G. L. Kucera, U. Bierbach, J. Med. Chem. 2008, 51, 7574.
4. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, M. J. Thun, CA Cancer J. Clin. 2009, 59, 225.
5. P. M. Takahara, A. C. Rosenzweig, C. A. Frederick, S. J. Lippard, Nature 1995, 377, 649.
6. D. Yang, S. S. G. E. vanBoom, J. Reedijk, J. H. vanBoom, A. H. J. Wang, Biochemistry 1995, 34, 12912.
7. E. R. Jamieson, S. J. Lippard, Chem. Rev. 1999, 99, 2467.
8. J. Reedijk, Proc. Natl. Acad. Sci. USA 2003, 100, 3611.
9. S. Komeda, H. Ohishi, H. Yamane, M. Harikawa, K.-i. Sakaguchi, M. Chikuma, J. Chem. Soc. Dalton Trans. 1999, 2959.
10. S. Komeda, M. Lutz, A. L. Spek, Y. Yamanaka, T. Sato, M. Chikuma, J. Reedijk, J. Am. Chem. Soc. 2002, 124, 4738.
11. S. Teletchea, S. Komeda, J. M. Teuben, M. A. Elizondo-Riojas, J. Reedijk, J. Kozelka, Chem. Eur. J. 2006, 12, 3741.
12. S. Komeda, M. Lutz, A. L. Spek, M. Chikuma, J. Reedijk, Inorg. Chem. 2000, 39, 4230.
13. A. H. Calvert, S. J. Harland, D. R. Newell, Z. H. Siddik, A. C. Jones, T. J. McElwain, S. Raju, E. Wiltshaw, I. E. Smith, J. M. Baker, M. J. Peckham, K. R. Harrap, Cancer Chemother. Pharmacol. 1982, 9, 140.
14. H. Sharma, N. Thatcher, J. Baer, A. Zaki, A. Smith, C. A. McAucliffe, D. Crowther, S. Owens, B. W. Fox, Cancer Chemother. Pharmacol. 1983, 11, 5.
15. T. Tashiro, Y. Kawada, Y. Sakurai, Y. Kidani, Biomed. Pharmacother. 1989, 43, 251.
16. E. Cvitkovic, Br. J. Cancer 1998, 77, 8.
17. S. M. Aris, N. P. Farrell, Eur. J. Inorg. Chem. 2009, 1293.
18. N. P. Farrell, Semin. Oncol. 2004, 31, 1.
19. B. Lippert, C. J. L. Lock, B. Rosenberg, M. Zvagulis, Inorg. Chem. 1978, 17, 2971.